Cancer Metastasis Alert and Prevention Center, Pharmaceutical Photocatalysis of State Key Laboratory of Photocatalysis on Energy and Environment, and Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, College of Chemistry, Fuzhou University, Fuzhou 350116, China.
Cancer Metastasis Alert and Prevention Center, Pharmaceutical Photocatalysis of State Key Laboratory of Photocatalysis on Energy and Environment, and Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, College of Chemistry, Fuzhou University, Fuzhou 350116, China.
Acta Biomater. 2018 Apr 1;70:197-210. doi: 10.1016/j.actbio.2018.01.028. Epub 2018 Feb 13.
UNLABELLED: Nanosized drug delivery systems (NDDS) with photothermal therapy (PTT) and photodynamic therapy (PDT) have been extensively exploited to improve the therapeutic performance and bio-safety of chemotherapeutic drugs in cancer. In this work, a carrier-free nanodrug was developed by co-assembly of the anti-cancer agent ursolic acid (UA), an asialoglycoprotein receptor (ASGPR), which can recognize the target molecule lactobionic acid (LA), and the near-infrared (NIR) probe dye indocyanine green (ICG) to form UA-LA-ICG NPs by a simple and green self-assembly approach. The UA-LA-ICG NPs had suitable stability, showed controlled release profile of UA drugs, and exhibited preferable temperature response (∼59.4 °C) under laser irradiation (808 nm, 1 W/cm). Compared with free ICG, the UA-LA-ICG NPs significantly enhanced the intracellular ICG uptake. Upon irradiation of the NIR laser, co-assembled nanodrugs demonstrated great performance as a reactive oxygen species (ROS) producer and exhibited more anti-proliferative activities on ASGPR-overexpressing HepG2 cells than ASGPR low-expressing HeLa cells. Meanwhile, in vivo NIR fluorescence imaging exhibited that the co-assembled nanodrugs were specifically targeted to the tumor by the active targeting property of LA, and its circulation time was much longer than that of free ICG. In addition, UA-LA-ICG NPs + NIR irradiation treatment displayed enhanced inhibitory effect on tumor growth in H22 tumor-bearing mice. Overall, the co-assembly of chemotherapeutic agent and photosensitizer by the self-assembly approach might open an alternative avenue and give inspiration to fabricate new carrier-free nanodrugs for cancer imaging and chemo-photo combination therapy. STATEMENT OF SIGNIFICANCE: The present study for the first time reported carrier-free nanoparticles (NPs) by co-assembly of a natural product ursolic acid (UA), an asialoglycoprotein receptor (ASGPR)-recognized sugar molecule lactobionic acid (LA), and the near-infrared dye indocyanine green (ICG) through a simple and green approach. The preparation process of nanodrugs is simple, rapid, effective, and labor-saving. The co-assembled nanodrugs were capable of stabilizing the ICG molecules and specifically targeting to the tumor, which could increase the tumor accumulation in cancer imaging and also enhance the efficacy of chemo-phototherapy.
未加标签:纳米药物递送系统(NDDS)与光热疗法(PTT)和光动力疗法(PDT)相结合,已被广泛用于提高癌症化疗药物的治疗效果和生物安全性。在这项工作中,通过将抗癌剂熊果酸(UA)、能够识别靶分子乳糖酸(LA)的唾液酸糖蛋白受体(ASGPR)和近红外(NIR)探针染料吲哚菁绿(ICG)共同组装,制备了一种无载体纳米药物,通过简单、绿色的自组装方法形成 UA-LA-ICG NPs。UA-LA-ICG NPs 具有适宜的稳定性,UA 药物的释放呈控释特征,在激光照射(808nm,1W/cm)下表现出较好的温度响应(~59.4°C)。与游离 ICG 相比,UA-LA-ICG NPs 显著增加了细胞内 ICG 的摄取。在近红外激光照射下,共组装纳米药物作为活性氧(ROS)产生剂表现出优异的性能,并对高表达 ASGPR 的 HepG2 细胞显示出比低表达 ASGPR 的 HeLa 细胞更强的抗增殖活性。同时,体内近红外荧光成像显示,共组装纳米药物通过 LA 的主动靶向特性特异性靶向肿瘤,其循环时间远长于游离 ICG。此外,UA-LA-ICG NPs+NIR 照射治疗对 H22 荷瘤小鼠的肿瘤生长显示出增强的抑制作用。总的来说,通过自组装方法将化疗药物和光敏剂共组装可能为癌症成像和化疗-光疗联合治疗开辟一条替代途径,并为制备新型无载体纳米药物提供启示。
ACS Appl Mater Interfaces. 2017-12-6
Colloids Surf B Biointerfaces. 2022-1
Int J Nanomedicine. 2025-7-28
Bioimpacts. 2024-10-27
J Nanobiotechnology. 2025-2-19
J Nanobiotechnology. 2025-2-14
Research (Wash D C). 2025-1-17
Adv Sci (Weinh). 2024-9
J Nanobiotechnology. 2023-9-27